Artemis Technologies (Drug Discovery) Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Artemis Technologies (Drug Discovery) General Information

Description

Developer of oral rabies vaccine based in Ontario, Canada. The company specializes in producing rabies glycoprotein recombinant oral vaccines licensed for use in striped skunks in partnership with government authorities, helping eliminate rabies in the wildlife.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 51 Watson Road South
  • Guelph, Ontario N1L 1E3
  • Canada
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 51 Watson Road South
  • Guelph, Ontario N1L 1E3
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Artemis Technologies (Drug Discovery) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Artemis Technologies (Drug Discovery)‘s full profile, request access.

Request a free trial

Artemis Technologies (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Artemis Technologies (Drug Discovery) FAQs

  • When was Artemis Technologies (Drug Discovery) founded?

    Artemis Technologies (Drug Discovery) was founded in 1997.

  • Where is Artemis Technologies (Drug Discovery) headquartered?

    Artemis Technologies (Drug Discovery) is headquartered in Guelph, Canada.

  • What is the size of Artemis Technologies (Drug Discovery)?

    Artemis Technologies (Drug Discovery) has 13 total employees.

  • What industry is Artemis Technologies (Drug Discovery) in?

    Artemis Technologies (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Artemis Technologies (Drug Discovery) a private or public company?

    Artemis Technologies (Drug Discovery) is a Private company.

  • What is Artemis Technologies (Drug Discovery)’s current revenue?

    The current revenue for Artemis Technologies (Drug Discovery) is .

  • When was Artemis Technologies (Drug Discovery) acquired?

    Artemis Technologies (Drug Discovery) was acquired on 16-May-2022.

  • Who acquired Artemis Technologies (Drug Discovery)?

    Artemis Technologies (Drug Discovery) was acquired by Ceva Santé Animale.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process